SAN FRANCISCO — Ensuring safe and effective products are available to the American people is the mission of the FDA Center for Drug Evaluation and Research, which is why there is a reason behind everything the FDA asks for when studying new drug products, according to a speaker at Glaucoma 360: New Horizons Forum.

“One of my biggest frustrations is for people to do something that they think the FDA wants them to do. The company doesn’t necessarily have to do it, and the FDA doesn’t think it’s necessary. All that does is waste resources,” Wiley Chambers, MD, supervisory medical officer of new drugs at the FDA, said in a presentation.